Evidence map›Paper›PMID 27752079›Full record

ArticleMolecular psychiatry2018

DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/β-catenin signaling.

P-M Martin, R E Stanley, A P Ross, A E Freitas, C E Moyer, A C Brumback, J Iafrati, K S Stapornwongkul, S Dominguez, S Kivimäe and 10 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Smoking and tetramer tryptase accelerate intervertebral disc degeneration by inducing METTL14-mediated DIXDC1 mMolecular therapy : the journal of the American Society of Gene Therapy · 2023
    Article
  9. Article
  10. CTNNB1 in neurodevelopmental disorders.Frontiers in psychiatry · 2023
    Review
  11. Article
  12. Article
  13. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.The international journal of neuropsychopharmacology · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

P-M MartinDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
R E StanleyDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
A P RossDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
A E FreitasDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
C E MoyerDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, USA.
A C BrumbackDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
J IafratiDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
K S StapornwongkulDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
S DominguezDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
S KivimäeDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
K A MulliganDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
M PiroozniaDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, MD, USA.
W R McCombieStanley Institute for Cognitive Genomics, Cold Spring Harbor Laboratory, Woodbury, NY, USA.
J B PotashDepartment of Psychiatry, University of Iowa Carver College of Medicine, Iowa City, IA, USA.
P P ZandiDepartment of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
S M PurcellInstitute for Genomics and Multiscale Biology, Department of Psychiatry and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
S J SandersDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
Y ZuoDepartment of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, USA.
V S SohalDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
B N R CheyetteDepartment of Psychiatry, University of California San Francisco (UCSF), San Francisco, CA, USA.
University of California, San Francisco · USJohns Hopkins University · USUniversity of California, Santa Cruz · USCold Spring Harbor Laboratory · USIcahn School of Medicine at Mount Sinai · USUniversity of Iowa · US

Funding

2/2-Rare Bipolar Loci Identification Through Synaptome Sequencing.R01MH087992 · NIMH · COLD SPRING HARBOR LABORATORY · PI MCCOMBIE, WILLIAM RICHARD · 2010 to 2014
$3.9M
The Dact/Sestd1 pathway in embryonic malformationsR01HD055300 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHEYETTE, BENJAMIN N.R. · 2007 to 2017
$3.4M
Cellular and synaptic mechanisms for dopaminergic modulation of prefrontal cortexR01MH100292 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SOHAL, VIKAAS SINGH · 2013 to 2017
$2.5M
Dynamics and molecular mechanism of synaptic connectivity change during learningR01MH104227 · NIMH · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI ZUO, YI · 2014 to 2018
$2.1M
1/2 Rare Bipolar Loci identification through Synaptome SequencingR01MH087979 · NIMH · UNIVERSITY OF IOWA · PI POTASH, JAMES B. · 2010 to 2014
$2.0M
Neurovascular Mechanisms of Time-Dependencies in Stroke RehabilitationR01NS078791 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI DUNN, ANDREW K, JONES, THERESA A · 2012 to 2016
$1.7M
Development of synaptic abnormality in fragile X miceR01MH094449 · NIMH · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI ZUO, YI · 2012 to 2015
$1.5M
Neurobiological Mechanisms Underlying the Symptoms and Course of SchizophreniaT32MH089920 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FORD, JUDITH M · 2010 to 2014
$1.3M
Prefrontal corticothalamic circuits in autismK08NS094643 · NINDS · UNIVERSITY OF TEXAS AT AUSTIN · PI BRUMBACK, AUDREY CHRISTINE · 2015 to 2019
$893k
Novel Analytic Methods for Rare Variant Detection in Bipolar DisorderK01MH093809 · NIMH · JOHNS HOPKINS UNIVERSITY · PI PIROOZNIA, MEHDI · 2011 to 2015
$886k
NICHD NIH HHS R01 HD055300NIMH NIH HHS K01 MH093809NIMH NIH HHS R01 MH087979NIMH NIH HHS R01 MH087992NIMH NIH HHS R01 MH094449NIMH NIH HHS R01 MH100292NIMH NIH HHS R01 MH104227NIMH NIH HHS T32 MH089920NINDS NIH HHS K08 NS094643NINDS NIH HHS R01 NS078791
6 · The paper itself

Abstract

Mice lacking DIX domain containing-1 (DIXDC1), an intracellular Wnt/β-catenin signal pathway protein, have abnormal measures of anxiety, depression and social behavior. Pyramidal neurons in these animals' brains have reduced dendritic spines and glutamatergic synapses. Treatment with lithium or a glycogen synthase kinase-3 (GSK3) inhibitor corrects behavioral and neurodevelopmental phenotypes in these animals. Analysis of DIXDC1 in over 9000 cases of autism, bipolar disorder and schizophrenia reveals higher rates of rare inherited sequence-disrupting single-nucleotide variants (SNVs) in these individuals compared with psychiatrically unaffected controls. Many of these SNVs alter Wnt/β-catenin signaling activity of the neurally predominant DIXDC1 isoform; a subset that hyperactivate this pathway cause dominant neurodevelopmental effects. We propose that rare missense SNVs in DIXDC1 contribute to psychiatric pathogenesis by reducing spine and glutamatergic synapse density downstream of GSK3 in the Wnt/β-catenin pathway.

Indexed as

AnimalsAnxietyAnxiety Disordersbeta CateninDendritic SpinesDepressionDepressive DisorderGlutamate Plasma Membrane Transport ProteinsGlycogen Synthase Kinase 3Intracellular Signaling Peptides and ProteinsMental DisordersMiceMice, KnockoutPolymorphism, Single NucleotidePyramidal CellsSocial Behaviorbeta CateninDixdc1 protein, mouseGlutamate Plasma Membrane Transport ProteinsGlycogen Synthase Kinase 3Intracellular Signaling Peptides and Proteins

Identifiers

PMID27752079
PMCPMC5395363
OpenAlexW2537745220

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.